Cardinal Health Net Income
| CAH Stock | USD 225.58 4.79 2.17% |
As of the 18th of February 2026, Cardinal Health shows the Risk Adjusted Performance of 0.077, downside deviation of 1.6, and Mean Deviation of 1.14. Cardinal Health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Cardinal Health Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.2379 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 1.8 B | 1.9 B | |
| Net Income Applicable To Common Shares | 1.4 B | 1.5 B | |
| Net Income From Continuing Ops | 1.4 B | 1.5 B | |
| Net Income Per Share | 0.42 | 0.40 | |
| Net Income Per E B T | 0.62 | 0.52 |
Cardinal | Net Income | Build AI portfolio with Cardinal Stock |
The Net Income trend for Cardinal Health offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Cardinal Health is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Cardinal Health's Net Income Growth Pattern
Below is the plot of the Net Income of Cardinal Health over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Cardinal Health financial statement analysis. It represents the amount of money remaining after all of Cardinal Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Cardinal Health's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardinal Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 1.57 B | 10 Years Trend |
|
Net Income |
| Timeline |
Cardinal Net Income Regression Statistics
| Arithmetic Mean | 619,238,676 | |
| Geometric Mean | 740,968,581 | |
| Coefficient Of Variation | 214.12 | |
| Mean Deviation | 873,961,263 | |
| Median | 1,069,000,000 | |
| Standard Deviation | 1,325,903,693 | |
| Sample Variance | 1758020.6T | |
| Range | 5.6B | |
| R-Value | 0.09 | |
| Mean Square Error | 1858985.5T | |
| R-Squared | 0.01 | |
| Significance | 0.72 | |
| Slope | 24,432,132 | |
| Total Sum of Squares | 28128329.7T |
Cardinal Net Income History
Other Fundumenentals of Cardinal Health
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Cardinal Health Net Income component correlations
Cardinal Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Cardinal Health is extremely important. It helps to project a fair market value of Cardinal Stock properly, considering its historical fundamentals such as Net Income. Since Cardinal Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cardinal Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cardinal Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Providers & Services market expansion? Will Cardinal introduce new products? Factors like these will boost the valuation of Cardinal Health. Projected growth potential of Cardinal fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Cardinal Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.194 | Dividend Share 2.038 | Earnings Share 6.95 | Revenue Per Share | Quarterly Revenue Growth 0.188 |
The market value of Cardinal Health is measured differently than its book value, which is the value of Cardinal that is recorded on the company's balance sheet. Investors also form their own opinion of Cardinal Health's value that differs from its market value or its book value, called intrinsic value, which is Cardinal Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Cardinal Health's market value can be influenced by many factors that don't directly affect Cardinal Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Cardinal Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cardinal Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Cardinal Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cardinal Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cardinal Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cardinal Health.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in Cardinal Health on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Cardinal Health or generate 0.0% return on investment in Cardinal Health over 90 days. Cardinal Health is related to or competes with BioAffinity Technologies, Artelo Biosciences, Revelation Biosciences, WORK Medical, GT Biopharma, Psyence Biomedical, and Protagenic Therapeutics. Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, E... More
Cardinal Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cardinal Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cardinal Health upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.6 | |||
| Information Ratio | 0.0612 | |||
| Maximum Drawdown | 13.93 | |||
| Value At Risk | (2.43) | |||
| Potential Upside | 2.54 |
Cardinal Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cardinal Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cardinal Health's standard deviation. In reality, there are many statistical measures that can use Cardinal Health historical prices to predict the future Cardinal Health's volatility.| Risk Adjusted Performance | 0.077 | |||
| Jensen Alpha | 0.1668 | |||
| Total Risk Alpha | 0.0562 | |||
| Sortino Ratio | 0.0714 | |||
| Treynor Ratio | (0.68) |
Cardinal Health February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.077 | |||
| Market Risk Adjusted Performance | (0.67) | |||
| Mean Deviation | 1.14 | |||
| Semi Deviation | 1.42 | |||
| Downside Deviation | 1.6 | |||
| Coefficient Of Variation | 1115.25 | |||
| Standard Deviation | 1.86 | |||
| Variance | 3.47 | |||
| Information Ratio | 0.0612 | |||
| Jensen Alpha | 0.1668 | |||
| Total Risk Alpha | 0.0562 | |||
| Sortino Ratio | 0.0714 | |||
| Treynor Ratio | (0.68) | |||
| Maximum Drawdown | 13.93 | |||
| Value At Risk | (2.43) | |||
| Potential Upside | 2.54 | |||
| Downside Variance | 2.54 | |||
| Semi Variance | 2.01 | |||
| Expected Short fall | (1.26) | |||
| Skewness | 1.66 | |||
| Kurtosis | 11.16 |
Cardinal Health Backtested Returns
Cardinal Health is very steady at the moment. Cardinal Health secures Sharpe Ratio (or Efficiency) of 0.082, which signifies that the company had a 0.082 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Cardinal Health, which you can use to evaluate the volatility of the firm. Please confirm Cardinal Health's Mean Deviation of 1.14, risk adjusted performance of 0.077, and Downside Deviation of 1.6 to double-check if the risk estimate we provide is consistent with the expected return of 0.16%. Cardinal Health has a performance score of 6 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.23, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Cardinal Health are expected to decrease at a much lower rate. During the bear market, Cardinal Health is likely to outperform the market. Cardinal Health right now shows a risk of 1.97%. Please confirm Cardinal Health semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to decide if Cardinal Health will be following its price patterns.
Auto-correlation | -0.07 |
Very weak reverse predictability
Cardinal Health has very weak reverse predictability. Overlapping area represents the amount of predictability between Cardinal Health time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cardinal Health price movement. The serial correlation of -0.07 indicates that barely 7.0% of current Cardinal Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.07 | |
| Spearman Rank Test | -0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 54.68 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Cardinal Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Cardinal Health reported net income of 1.57 B. This is 359.74% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 174.79% lower than that of the firm.
Cardinal Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cardinal Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cardinal Health could also be used in its relative valuation, which is a method of valuing Cardinal Health by comparing valuation metrics of similar companies.Cardinal Health is currently under evaluation in net income category among its peers.
Cardinal Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Cardinal Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cardinal Health's managers, analysts, and investors.Environmental | Governance | Social |
Cardinal Health Institutional Holders
Institutional Holdings refers to the ownership stake in Cardinal Health that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Cardinal Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Cardinal Health's value.| Shares | Jpmorgan Chase & Co | 2025-06-30 | 2.5 M | Legal & General Group Plc | 2025-06-30 | 2.3 M | Wellington Management Company Llp | 2025-06-30 | 2.3 M | Marshall Wace Asset Management Ltd | 2025-06-30 | 1.9 M | T. Rowe Price Associates, Inc. | 2025-06-30 | 1.6 M | Goldman Sachs Group Inc | 2025-06-30 | 1.6 M | Victory Capital Management Inc. | 2025-06-30 | 1.6 M | Charles Schwab Investment Management Inc | 2025-06-30 | 1.5 M | Bank Of New York Mellon Corp | 2025-06-30 | 1.5 M | Vanguard Group Inc | 2025-06-30 | 30.6 M | Blackrock Inc | 2025-06-30 | 30.5 M |
Cardinal Fundamentals
| Return On Asset | 0.035 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 58.21 B | ||||
| Shares Outstanding | 235.32 M | ||||
| Shares Owned By Insiders | 0.26 % | ||||
| Shares Owned By Institutions | 92.37 % | ||||
| Number Of Shares Shorted | 5.09 M | ||||
| Price To Earning | 16.00 X | ||||
| Price To Book | 16.07 X | ||||
| Price To Sales | 0.22 X | ||||
| Revenue | 222.58 B | ||||
| Gross Profit | 9.04 B | ||||
| EBITDA | 3.11 B | ||||
| Net Income | 1.57 B | ||||
| Cash And Equivalents | 3.87 B | ||||
| Cash Per Share | 13.32 X | ||||
| Total Debt | 9.35 B | ||||
| Debt To Equity | 5.63 % | ||||
| Current Ratio | 1.04 X | ||||
| Book Value Per Share | (12.22) X | ||||
| Cash Flow From Operations | 2.4 B | ||||
| Short Ratio | 3.02 X | ||||
| Earnings Per Share | 6.95 X | ||||
| Price To Earnings To Growth | 1.59 X | ||||
| Target Price | 247.8 | ||||
| Number Of Employees | 53.08 K | ||||
| Beta | 0.66 | ||||
| Market Capitalization | 53.08 B | ||||
| Total Asset | 53.12 B | ||||
| Retained Earnings | 783 M | ||||
| Working Capital | (2.52 B) | ||||
| Current Asset | 21.96 B | ||||
| Current Liabilities | 19.7 B | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 3.61 % | ||||
| Net Asset | 53.12 B | ||||
| Last Dividend Paid | 2.04 |
About Cardinal Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cardinal Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardinal Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardinal Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is there potential for Health Care Providers & Services market expansion? Will Cardinal introduce new products? Factors like these will boost the valuation of Cardinal Health. Projected growth potential of Cardinal fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Cardinal Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.194 | Dividend Share 2.038 | Earnings Share 6.95 | Revenue Per Share | Quarterly Revenue Growth 0.188 |
The market value of Cardinal Health is measured differently than its book value, which is the value of Cardinal that is recorded on the company's balance sheet. Investors also form their own opinion of Cardinal Health's value that differs from its market value or its book value, called intrinsic value, which is Cardinal Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Cardinal Health's market value can be influenced by many factors that don't directly affect Cardinal Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Cardinal Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cardinal Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Cardinal Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.